TheEdgeResearch
Home / Stocks / RLBD

Real Brands, Inc. (RLBD)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$26,906
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.93
52-Wk Range
0.00001-0.0002
CEO
Thomas Kidrin
Country
US
Currency
USD

Real Brands, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in North Providence, RI, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $26,906. On trailing twelve-month figures it carries a trailing P/E of -0.02, a net margin of -2203.4%. Its beta of 0.93 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.02
Price / Sales
0.45
Price / Book
-0.02
EV / EBITDA
-0.84
Gross margin
-41.6%
Operating margin
-1970.1%
Net margin
-2203.4%
Return on equity
Debt / equity
-0.81
Current ratio
0.03
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2000-11-22
Headquarters
North Providence, RI, US
About Real Brands, Inc.

Real Brands, Inc. specializes in the comprehensive process of hemp-derived cannabidiol (CBD), from the extraction of CBD oil and isolate, through their wholesale distribution, to the manufacturing and retail of a diverse range of CBD-infused consumer products. Their extensive product line includes topical creams, gels, and lotions, cosmetic items, ingestible options like tinctures, oils, and capsules, as well as vape cartridges and oral sprays. Established in 2011, the company's corporate headquarters are situated in North Providence, Rhode Island.

Comparable companies

Real Brands, Inc. is most often compared with the following Healthcare names:

CWWBFFFNTFGPFTHMPQLRSVPEMTFPZOOSFLMVDRMVIVXF
More research on RLBD
RLBD technical analysis RLBD TheEdge Score Compare against peers
Open full interactive analysis & DCF →